Related Experiment Video
Updated: Apr 25, 2026
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Cardiovascular endocrinology: controversy--cardiovascular effects of calcium supplementation
1Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Insights
Calcium supplements may not increase heart attack or stroke risk, according to a new meta-analysis. However, the inclusion of controversial data means the debate on calcium supplement safety will continue.
Area of Science:
- Cardiovascular health
- Nutritional science
- Clinical research
Background:
- Previous studies and meta-analyses have raised concerns about potential links between calcium supplements and increased risk of myocardial infarction and stroke.
- Observational studies and clinical trial data have contributed to this ongoing debate regarding supplement safety.
Purpose of the Study:
- To re-evaluate the association between calcium supplement use and the risk of major adverse cardiovascular events.
- To address the existing controversy by incorporating previously omitted data into a comprehensive meta-analysis.
Main Methods:
- Conducted a new meta-analysis of clinical trial data, observational studies, and other relevant research.
- Included controversial data that was omitted from previous meta-analyses to provide a more complete picture.
Main Results:
- The updated meta-analysis suggests no significant increase in the risk of myocardial infarction or stroke associated with calcium supplement use.
- The inclusion of controversial data may alter previous conclusions, but the findings are subject to ongoing discussion.
Conclusions:
- The current meta-analysis indicates a potentially safer profile for calcium supplements than previously suggested.
- Further research and discussion are warranted due to the inclusion of controversial data and the persistence of the debate.
Abstract:
Of late, clinical trial data, meta-analyses and observational studies have caused concern that the use of calcium supplements might increase the risk of myocardial infarction and stroke. A new meta-analysis suggests that there is no problem with calcium supplements, but as the analysis includes controversial data omitted from previous analyses, the debate will continue.
More Related Videos
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
10:53Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:27Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...